1921
Volume 23, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645
USD

Abstract

Abstract

The effect of rifampin therapy in leprosy was studied in two clinical short-term trials in which skin punch biopsy specimens were taken at regular intervals for the inoculation of mice in order to monitor the decrease in proportion of viable in the patients' lesions. In a trial of rifampin in a dosage of 600 mg daily, the bacterial viability fell to undetectable levels in the first specimen taken after the start of therapy (at 3–4 days in 4 patients, 7–8 days in 9, and 14 days in 2). Dapsone-treated controls required 20 to more than 112 days for the same change. In a trial of a single dose of 1,500 mg rifampin, the viability fell to undetectable levels in the first specimen taken after the start of therapy also (at 3–5 days in all 14 patients).

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.1974.23.1120
1974-11-01
2017-11-20
Loading full text...

Full text loading...

http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.1974.23.1120
Loading
  • Accepted : 11 May 1974

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error